The objective of the present study was to compare gating properties of cardiac Nav1.5 and neuronal Nav1.7 channels, and their use-dependent inhibition by two drugs mexiletine and lidocaine that are widely used for cardiac arrhythmia and pain prevention. The gene discussed is SCN9A; the disease is cardiac rhythm disease.